148 related articles for article (PubMed ID: 32938193)
21. Validation of novel DNA methylation markers in cervical precancer and cancer.
El-Zein M; Cheishvili D; Szyf M; Franco EL
Int J Cancer; 2024 Jan; 154(1):104-113. PubMed ID: 37606371
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.
Verlaat W; Snijders PJF; Novianti PW; Wilting SM; De Strooper LMA; Trooskens G; Vandersmissen J; Van Criekinge W; Wisman GBA; Meijer CJLM; Heideman DAM; Steenbergen RDM
Clin Cancer Res; 2017 Jul; 23(14):3813-3822. PubMed ID: 28119363
[No Abstract] [Full Text] [Related]
23. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
Vink FJ; Lissenberg-Witte BI; Meijer CJLM; Berkhof J; van Kemenade FJ; Siebers AG; Steenbergen RDM; Bleeker MCG; Heideman DAM
Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459
[TBL] [Abstract][Full Text] [Related]
24. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
25. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
26. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
[TBL] [Abstract][Full Text] [Related]
27. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
28. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.
Snoek BC; Verlaat W; Babion I; Novianti PW; van de Wiel MA; Wilting SM; van Trommel NE; Bleeker MCG; Massuger LFAG; Melchers WJG; Sie D; Heideman DAM; Snijders PJF; Meijer CJLM; Steenbergen RDM
Int J Cancer; 2019 Jan; 144(2):372-379. PubMed ID: 30192375
[TBL] [Abstract][Full Text] [Related]
30. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis.
Kelly H; Benavente Y; Pavon MA; De Sanjose S; Mayaud P; Lorincz AT
Br J Cancer; 2019 Nov; 121(11):954-965. PubMed ID: 31616037
[TBL] [Abstract][Full Text] [Related]
31. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
[TBL] [Abstract][Full Text] [Related]
32. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
[TBL] [Abstract][Full Text] [Related]
34. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
Luttmer R; De Strooper LM; Dijkstra MG; Berkhof J; Snijders PJ; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; van Baal WM; Graziosi PG; Quint WG; Spruijt JW; van Dijken DK; Heideman DA; Meijer CJ
Br J Cancer; 2016 Aug; 115(5):579-87. PubMed ID: 27415009
[TBL] [Abstract][Full Text] [Related]
35. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
[TBL] [Abstract][Full Text] [Related]
36. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women.
Hansel A; Steinbach D; Greinke C; Schmitz M; Eiselt J; Scheungraber C; Gajda M; Hoyer H; Runnebaum IB; Dürst M
PLoS One; 2014; 9(3):e91905. PubMed ID: 24647315
[TBL] [Abstract][Full Text] [Related]
37. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
38. Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.
Brandsma JL; Harigopal M; Kiviat NB; Sun Y; Deng Y; Zelterman D; Lizardi PM; Shabanova VS; Levi A; Yaping T; Hu X; Feng Q
Cancer Prev Res (Phila); 2014 May; 7(5):526-33. PubMed ID: 24556390
[TBL] [Abstract][Full Text] [Related]
39. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.
Kremer WW; Steenbergen R; Heideman D; Kenter GG; Meijer C
BJOG; 2021 Feb; 128(3):504-514. PubMed ID: 32619334
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
